The Top Three Stocks to Watch in Asia Today

The video discusses the US Navy's planned expenditure of $81.4 billion on ships and submarines, which is expected to benefit the Australian company Austal. It also covers the stock performance of Tokyo Individualized Educational Institute, highlighting its growth despite slightly missing earnings estimates. Lastly, it examines Slice Mix, a medical company that has developed a colon cancer biopsy test with Merck, recently approved in Europe, leading to significant stock growth.

What is the expected impact of the US Navy's investment on Austal?

• It will likely decrease Austal's stock value.

• It is expected to have no impact on Austal.

• It should positively impact Austal's stock.

• It will cause Austal to lose contracts.

What type of business does Tokyo Individualized Educational Institute operate?

• A technology firm

• A cram school

• A financial advisory service

• A retail chain

How did Tokyo Individualized Educational Institute's earnings per share compare to estimates?

• They were slightly below estimates.

• They were significantly below estimates.

• They matched estimates.

• They were above estimates.

What recent development has occurred with Slice Mix's colon cancer biopsy test?

• It was rejected in Europe.

• It failed clinical trials.

• It received approval in Europe.

• It was approved in the US.

What has been the trend in Slice Mix's stock value over the past two years?

• It has remained stable.

• It has decreased by 50%.

• It has increased by 10%.

• It has doubled.